Naturhouse Health, S.A. (BME:NTH)
Spain · Delayed Price · Currency is EUR 2.270
+0.020 (0.89%)
Oct 27, 2026, 5:35 PM CET
Naturhouse Health Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 136 | 132 | 99 | 97 | 94 | 115 | |
Market Cap Growth | 8.70% | 32.93% | 2.16% | 2.86% | -18.18% | 24.19% |
Enterprise Value | 128 | 112 | 76 | 83 | 79 | 93 |
Last Close Price | 2.27 | 2.07 | 1.37 | 1.23 | 1.14 | 1.23 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.82 | 13.07 | 10.06 | 8.60 | 9.81 | 8.64 |
Forward PE | - | 13.75 | 9.74 | 11.37 | 7.68 | 8.46 |
PS Ratio | 3.03 | 2.77 | 2.01 | 1.93 | 1.80 | 2.00 |
PB Ratio | 8.89 | 7.43 | 3.13 | 3.17 | 3.39 | 3.20 |
P/TBV Ratio | 9.16 | 7.59 | 3.17 | 3.22 | 3.47 | 3.27 |
P/FCF Ratio | 12.68 | 11.30 | 8.84 | 4.76 | 15.40 | 7.16 |
P/OCF Ratio | 12.83 | 10.86 | 8.58 | 4.64 | 13.30 | 7.14 |
PEG Ratio | - | 9.89 | 9.89 | 9.89 | 8.54 | 0.51 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.85 | 2.36 | 1.54 | 1.65 | 1.51 | 1.62 |
EV/EBITDA Ratio | 11.06 | 8.34 | 5.63 | 4.95 | 5.92 | 4.70 |
EV/EBIT Ratio | 11.54 | 8.49 | 5.79 | 5.11 | 6.17 | 5.32 |
EV/FCF Ratio | 11.93 | 9.64 | 6.78 | 4.08 | 12.91 | 5.79 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.25 | 0.19 | 0.14 | 0.17 | 0.19 | 0.12 |
Debt / EBITDA Ratio | 0.34 | 0.24 | 0.29 | 0.27 | 0.36 | 0.22 |
Debt / FCF Ratio | 0.36 | 0.29 | 0.38 | 0.25 | 0.88 | 0.27 |
Net Debt / Equity Ratio | -0.53 | -0.62 | -0.55 | -0.63 | -0.24 | -0.63 |
Net Debt / EBITDA Ratio | -0.74 | -0.82 | -1.29 | -1.15 | -0.50 | -1.15 |
Net Debt / FCF Ratio | -0.75 | -0.95 | -1.55 | -0.95 | -1.10 | -1.42 |
Asset Turnover | 1.22 | 1.25 | 1.08 | 1.10 | 1.14 | 1.26 |
Inventory Turnover | 4.45 | 4.26 | 4.57 | 5.13 | 5.81 | 5.71 |
Quick Ratio | 1.30 | 1.40 | 3.83 | 2.23 | 2.54 | 4.21 |
Current Ratio | 1.56 | 1.65 | 4.36 | 2.69 | 3.23 | 4.62 |
Return on Equity (ROE) | 41.83% | 40.83% | 31.65% | 38.45% | 30.09% | 43.04% |
Return on Assets (ROA) | 18.35% | 21.77% | 17.96% | 22.20% | 17.49% | 23.95% |
Return on Invested Capital (ROIC) | 111.32% | 92.95% | 74.79% | 73.23% | 54.93% | 104.29% |
Return on Capital Employed (ROCE) | 55.60% | 61.40% | 36.40% | 45.10% | 37.30% | 42.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.32% | 7.65% | 9.94% | 11.63% | 10.20% | 11.58% |
FCF Yield | 7.89% | 8.85% | 11.31% | 20.98% | 6.49% | 13.97% |
Dividend Yield | 8.81% | 13.64% | 12.08% | - | 9.52% | 10.39% |
Payout Ratio | 225.83% | 178.32% | 121.67% | 53.13% | 186.97% | 26.94% |
Total Shareholder Return | 8.77% | 13.64% | 12.08% | - | 9.52% | 10.39% |